| Trial ID: | L4129 |
| Source ID: | NCT01134224
|
| Associated Drug: |
Insulin Degludec/Insulin Aspart
|
| Title: |
A Trial Investigating the Effect of NN5401 in Subjects With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin degludec/insulin aspart|DRUG: insulin degludec/insulin aspart|DRUG: insulin degludec/insulin aspart|DRUG: biphasic insulin aspart 30|DRUG: biphasic insulin aspart 30|DRUG: biphasic insulin aspart 30
|
| Outcome Measures: |
Primary: Area under the glucose infusion rate curve (only for IDegAsp), From 0 to 24 hours after single-dose | Secondary: Area under the insulin aspart concentration-time curve, From 0 to 12 hours after single-dose administration|Area under the insulin aspart concentration-time curve (only for BIAsp 30), From 0 to 24 hours after single-dose administration
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
39
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2010-05
|
| Completion Date: |
2010-11
|
| Results First Posted: |
|
| Last Update Posted: |
2013-11-27
|
| Locations: |
Neuss, 41460, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT01134224
|
